High-Dose Influenza Vaccine to Reduce Hospitalizations
New England Journal of Medicine · 11.12.2025 · 393 (23) · 2303-2312
DOI: 10.1056/nejmoa2509834 ↗Kurz gefasst
Klinische Studie (Phase IV) in der Zeitschrift New England Journal of Medicine, erschienen am 11.12.2025. Verfasst von Jacobo Pardo-Seco und 24 weiteren Autor:innen. Beteiligte Einrichtung: Genetics, Vaccines, and Infectious Diseases Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela,…. Hauptthemen laut MEDLINE: Hospitalization, Influenza Vaccines, Influenza, Human, Vaccine Efficacy. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 13 Literaturangaben. Gefördert von: Sanofi, Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Salud Mental.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Genetics, Vaccines, and Infectious Diseases Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain.
- World Health Organization Collaborating Center for Vaccine Safety, Santiago de Compostela, Spain.
- Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid.
- GenPoB Research Group, IDIS, Hospital Clínico Universitario de Santiago, Servizo Galego de Saúde (SERGAS), Santiago de Compostela, Spain.
- Instituto de Ciencias Forenses "Luis Concheiro" (INCIFOR), Universidade de Santiago de Compostela, Santiago de Compostela, Spain.
- Translational Pediatrics and Infectious Diseases, SERGAS, Santiago de Compostela, Spain.
ORCID-Profile: Iago Giné-Vázquez, Josefina Lorena Razzini, Niklas Dyrby Johansen, Daniel Modin
Förderung
- Sanofi
- Instituto de Salud Carlos III
- Centro de Investigación Biomédica en Red de Salud Mental
- Axencia Galega de Innovación
- Consorcio centro de investigacion biomedica en red de enfermedades respiratorias
- GAIN, Xunta de Galicia
Zitieren
APA
Pardo-Seco, J., Rodríguez-Tenreiro-Sánchez, C., Giné-Vázquez, I., Mallah, N., Mirás-Carballal, S., Piñeiro-Sotelo, M., Cribeiro-González, M., Conde-Pájaro, M., González-Pérez, J. M., Rivero-Calle, I., Bello, X., Razzini, J. L., Dacosta-Urbieta, A., Salas, A., Harris, R. C., Loiacono, M. M., van Aalst, R., Farré, J. M., Dufournet, M., …, & GALFLU Trial Team (2025). High-Dose Influenza Vaccine to Reduce Hospitalizations. New England Journal of Medicine, 393(23), 2303-2312. https://doi.org/10.1056/nejmoa2509834
Vancouver
Pardo-Seco J, Rodríguez-Tenreiro-Sánchez C, Giné-Vázquez I, Mallah N, Mirás-Carballal S, Piñeiro-Sotelo M, et al. High-Dose Influenza Vaccine to Reduce Hospitalizations. New England Journal of Medicine. 2025;393(23):2303-2312. doi:10.1056/nejmoa2509834
BibTeX
@article{PardoSeco2025,
author = {Pardo-Seco, Jacobo and Rodríguez-Tenreiro-Sánchez, Carmen and Giné-Vázquez, Iago and Mallah, Narmeen and Mirás-Carballal, Susana and Piñeiro-Sotelo, Marta and Cribeiro-González, Martín and Conde-Pájaro, Mónica and González-Pérez, Juan-Manuel and Rivero-Calle, Irene and Bello, Xabier and Razzini, Josefina Lorena and Dacosta-Urbieta, Ana and Salas, Antonio and Harris, Rebecca C and Loiacono, Matthew M and van Aalst, Robertus and Farré, Joan Manel and Dufournet, Marine and Johansen, Niklas Dyrby and Modin, Daniel and Biering-Sørensen, Tor and Durán-Parrondo, Carmen and Martinón-Torres, Federico and GALFLU Trial Team, GALFLU Trial Team},
title = {High-Dose Influenza Vaccine to Reduce Hospitalizations},
journal = {New England Journal of Medicine},
year = {2025},
volume = {393},
number = {23},
pages = {2303--2312},
doi = {10.1056/nejmoa2509834}
}
EUVIMED